Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SensoLeak is an Israeli technology company specializing in AI-driven anomaly detection and predictive maintenance for critical infrastructure and healthcare. While the company's core business serves the oil, gas, and water industries by monitoring pipelines for leaks, it has successfully adapted its proprietary machine learning algorithms for medical applications. Specifically, SensoLeak offers a sophisticated system for detecting blood leakage during hemodialysis, addressing the critical risk of Venous Needle Dislodgement (VND). By integrating optical sensors with real-time data analysis, the platform provides high-sensitivity monitoring to improve patient safety in clinical and home-care settings. The company's technology is designed to minimize false positives while ensuring rapid response to potential medical emergencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SensoLeak.